Results 71 to 80 of about 5,686,554 (263)

COMPANY FINANCIAL DIAGNOSIS IN CEE COUNTRIES [PDF]

open access: yesAnnals of the University of Petrosani: Economics, 2010
This paper focuses on developed versus emerging markets arbitrage in terms of investors’ perception. We first perform a literature review on the topic, highlighting out both disconnection and transmission belt theories. Then we conduct a deep comparative
PETRE BREZEANU   +2 more
doaj  

Economic & Financial Modelling: Summer 2021

open access: yes, 2021
Volume 28 Number 2Economic & Financial Modelling presents recent advances in all aspects of economic modelling. It is intended that the journal should act as a forum for new developments in different aspects of economic and financial modelling - covering
European Economics and Financial Centre
core  

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan   +5 more
wiley   +1 more source

Diagnosing companies in financial difficulty based on the auditor’s report

open access: yesCroatian Operational Research Review, 2016
The approach used in this paper expands on existing research that focuses on devising prediction models for companies experiencing financial difficulties and which in turn serves as a criteria-based diagnosis tool for distinguishing healthy companies ...
Robert Zenzerović, Martin Valić-Vale
doaj   +1 more source

Financial Coaching Training Rubric

open access: yes, 2017
Coaching Skills & Practice, Coaching Theory, Financial Foundations, Cultural Responsiveness, Administration, Training Logistics, Continued Support and ...
Center for Financial Security
core  

Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket   +14 more
wiley   +1 more source

Financial Coaching: Review of Existing Research

open access: yes, 2017
This brief summarizes research into the theories underlying financial coaching and the effects of financial coaching on participant ...
Center for Financial Security
core  

Early Clinical, Imaging, and Pathological Characteristics of SRPK3/TTN‐Digenic Myopathy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective SRPK3/TTN‐digenic myopathy was recently established as a skeletal muscle myopathy caused by digenic inheritance. This study characterizes the early clinical presentation of SRPK3/TTN‐digenic myopathy in one previously reported and seven newly identified pediatric patients.
Rotem Orbach   +23 more
wiley   +1 more source

The East Asian Financial Crisis: Diagnosis, Remedies, Prospects [PDF]

open access: yes
macroeconomics, East Asian Financial Crisis, East Asia, Financial crisis, Diagnosis, Remedies ...
Steven Radelet, Jeffrey D. Sachs
core  

Association Between Motor Pathway Damage and Motor Deficit in Upper and Lower Limb in People With MS

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Corticospinal tract damage is common in people with MS, but the degree of clinical symptoms varies. We hypothesize that corticospinal tract lesions are more extensive and severe in people with MS with motor impairments in both upper and lower limbs.
Mathilde Liffran   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy